InMode Announces Launch of EvolveX Body Transforming Platform
InMode Ltd. (Nasdaq: INMD) has launched the EvolveX platform featuring Transform technology, designed for hands-free, non-invasive body transformation with zero downtime. The platform meets rising post-lockdown demand for non-surgical treatments, offering a unique all-in-one solution that remodels skin, treats fat, and sculpts muscles. EvolveX’s innovative features allow physicians to customize treatments addressing specific patient needs, promising consistent results. CEO Moshe Mizrahy emphasized the growing demand for such solutions, backed by InMode's strong R&D pipeline.
- Launch of EvolveX platform with Transform technology enhances product offerings.
- EvolveX addresses growing demand for non-invasive treatments post-lockdown.
- The platform provides versatile treatment options tailored to individual patient needs.
- None.
IRVINE, Calif., Sept. 1, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to announce the launch of the EvolveX platform with Transform technology.
EvolveX is a hands-free, zero downtime full body transforming solution. Post-lockdown, patients continue to pursue non-invasive treatments at unprecedented levels, searching for nonsurgical alternatives to achieve toned sculpted physiques. EvolveX is the only all-in-one system equipped with clinically proven technologies to remodel skin, treat fat, and sculpt muscles. The versatility of EvolveX multi-modalities allows physicians to focus on individual patient needs by selectively or synergistically delivering procedures that produce consistent transformative results.
Moshe Mizrahy, InMode CEO, commented, "As the world begins to return to a new state of normal, the demand for hands-free, social distancing platforms continues to grow beyond our original projections. InMode's platforms provide physicians and patients with the most sought-after treatments."
"InMode's strategic mandate to deliver innovative solutions drives our robust R&D pipeline and highly successful commercialization stream. The novel Transform technology on EvolveX is another example of our unwavering commitment to provide superior, comprehensive technologies for our existing and future customers," said Shakil Lakhani, InMode North American President.
Dr. Spero Theodorou, InMode Chief Medical Officer and Plastic Surgeon commented, "EvolveX with the new Transform technology is revolutionizing non-invasive body contouring. Combined, EvolveX Tite, Tone, and Transform technologies allow for adjustable real-time procedures specific to individual patient needs. Treatments can be tailored to either selectively or simultaneously focus on loose skin, fat, and muscle."
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Press Contact:
Behrman Communications
Amanda Reinstein
areinstein@behrmanpr.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
Tel: 917-607-8654
View original content:https://www.prnewswire.com/news-releases/inmode-announces-launch-of-evolvex-body-transforming-platform-301366678.html
SOURCE InMode Ltd.
FAQ
What is InMode's new product EvolveX and its features?
When was EvolveX launched by InMode?
How does EvolveX cater to patient needs?
What technology does the EvolveX platform utilize?
What impact does the launch of EvolveX have on InMode's market position?
